Abbott India Limited Abbott India Limited

Abbott India Limited

ABBOTINDIA

Rang in Aktien #3029
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Aktienkurs
$284.73
Marktkapitalisierung
$6.05B
Veränderung (1 Tag)
-0.41%
Veränderung (1 Jahr)
-17.16%
Land
IN
Handel Abbott India Limited (ABBOTINDIA)

Kategorie

Healthcare
P/B-Verhältnis für Abbott India Limited (ABBOTINDIA)
P/B-Verhältnis zum October 2026 TTM: 11.63
Laut den neuesten Finanzberichten und dem Aktienkurs von Abbott India Limited beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 11.63. Am Ende des Jahres 2024 lag das P/B-Verhältnis bei 15.81.
P/B-Verlauf für Abbott India Limited von 2004 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 11.63 -23.56%
2025 15.22 -3.74%
2024 15.81 7.52%
2023 14.70 10.22%
2022 13.34 9.03%
2021 12.24 -9.38%
2020 13.50 74.90%
2019 7.72 12.00%
2018 6.89 -3.10%
2017 7.11 -14.94%
2016 8.36 -6.65%
2015 8.96 89.24%
2014 4.73 -2.69%
2012 4.87 -14.72%
2011 5.71 -2.76%
2010 5.87 44.37%
2009 4.06 -22.69%
2008 5.26 1.18%
2007 5.20 3.57%
2006 5.02 -11.95%
2005 5.70 -13.01%
2004 6.55 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
31.9092 174.26%
US
7.3138 -37.14%
US
-84.6033 -827.17%
US
8.6873 -25.33%
US
8.4776 -27.13%
CH